Healthcare

Ramsay Health Care provides private healthcare across Australia, the UK and Europe. Its 2026 disclosures show aBusinessfocused on improving performance in its Australian hospital network while reshaping the group structure through the proposed separation of Ramsay Santé. The period also featured continued investment in …

For the year ended 30 June 2026, Sonic reported revenue of A$10.867 billion, an increase of 13%. Underlying EBITDA rose 11% to A$1.933 billion and underlying net profit increased 17% to A$621 million. Organic revenue growth was 5%, reflectingDemandacross the group’s established diagnostic operations …

AFT Pharmaceuticals Limited (ASX:AFP) is a multinational pharmaceutical company that develops, markets and distributes a broad portfolio of proprietary and in-licensed medicines across over-the-counter, prescription and hospital channels. Its 6 October 2026 update outlined regulatory progress for Scomara, continued growth across its operating divisions …

Epiminder Ltd is a medical-device and information-solutions company developing continuous brain-monitoring technology for epilepsy and other seizure disorders. Its core product, Minder, is a minimally invasive system designed to record electrographic brain activity over extended periods while patients continue normal daily activities. Epiminder shares …

EchoIQ develops software intended to assist clinicians in reviewing echocardiographic measurements. The company states that its technology uses measurement-based artificial intelligence rather than image analysis, allowing the platform to work with data already generated during routine echocardiography. Its commercial product, EchoSolv AS, is designed …

On October 7, 2026, Gentrack Group Ltd (ASX:GTK) changed hands at AUD 3.30, marking a 3.45% rise during today's trading session. Gentrack is a technology-focused company providing software and services to utilities and airports. Its currentInvestmentand operating focus centres on recurring revenue growth, international …

GI Navigator uses a single at-home stool sample together with a 15-minute patient questionnaire. It provides full microbiome mapping, pathogen screening and an assessment of gut physiology, with results available within two to four weeks.